CalciMedica sets mid-2027 targets for PH data and CM5480 IND, cash runs into H2 2027Nov 10Quarterly updateCalciMedica, Inc.
CalciMedica files prospectus supplement for up to $25 million stock saleSep 30FinancingCalciMedica, Inc.
CalciMedica stockholders back plan increase, reverse split, and warrant issuances at annual meetingAug 19PeopleCalciMedica, Inc.
CalciMedica reports Q2 2026 results, advances pulmonary hypertension and pancreatitis programsAug 11Quarterly updateCalciMedica, Inc.